Trade Report: Top 10 Neurology Innovators in 2025
As cannabinoid-based pharmaceuticals move from fringe therapy to mainstream treatment, a new class of biopharmaceutical innovators is capturing attention from regulators, clinicians, and investors alike. From neurological disorders like refractory epilepsy to inflammation and pain management, cannabis-derived therapies especially redefining global markets. This report provides a comparative analysis of 10 leading companies in the cannabis pharmaceutical […]